Go to BioCentury homepage
Print this Print this

Welcome to BCIQ: BioCentury Online Intelligence.
Free access to this and other abridged company profiles is provided to all subscribers to SciBX: Science-Business eXchange.

Please explore the profile and if you wish to find out more about BCIQ - please Click Here

Bial-Portela & Ca. S.A.

Print preview Print preview

Collapse Summary

General Information

 Location S. Mamede do Coronado, Portugal
 Region
 Country Portugal
 Business Category Neurology, Cardiovascular
 Year Founded 1924
 Website www.bial.com
 Development Status Market (drug) (01/07/2008)

Archive Items are loading

Collapse Summary

Pipeline Information

Disease CategoryResearchPhase IPhase I/IIPhase IIPhase II/IIIPhase IIIRegistrationApprovedMarketed
Cardiovascular

-

-

-

2

-

-

-

-

-

Neurology

-

-

-

1

-

-

-

1

-

Total

-

-

-

3

-

-

-

1

-


Pipeline Details - Originated and out-licensed products (4 records)

Product Names

Disease Category

Standard Indication

Partners

Milestones

Latest Stage of Development

BIA 2-093 (Compound #), SEP-0002093 (Compound #), eslicarbazepine acetate (Generic), Exalief (Other), Stedesa (Other), Zebinix (Other)

Neurology

Epilepsy

Eisai Co. Ltd.; Sepracor Inc.

PDUFA date approval (01/30/2010)

Approved

BIA 5-453 (Compound #)

Cardiovascular

Congestive heart failure (CHF)

 

 

Phase II


Pipeline Details - In-licensed products